Lexology (registration) A racemic mixture of the two lansoprazole enantiomers, dexlansoprazole and levlansoprazole, is currently marketed by Takeda as the drug PREVACID, also used for the treatment GERD. In August of 2009, Takeda Canada Inc. filed a New Drug Submission ...
MedCity News Moody's believes that, despite its challenges, Teva will benefit from new product launches, a focus on innovative products, increased penetration of generic drugs in international markets and cost reductions. If successful, Teva could reduce its cost ... and more »
Globe and Mail A bioprocessing engineer shows a shaker flask where cells in growth medium are cultured in a laboratory at Dutch biotech company uniQurein in Amsterdam Dec. 13, 2012. The cells are being used as tiny factories to produce the gene therapy drug Glybera.
